Press Releases
Note: below you may find press releases about Trajenta® that were issued prior to January 1, 2020. Prior to this date, Boehringer Ingelheim and Eli Lilly and Company jointly commercialised Trajenta®. Since the beginning of 2020, Boehringer Ingelheim remains the sole entity responsible for commercialisation of Trajenta® worldwide. All inquiries related to Trajenta® should be directed to Boehringer Ingelheim.